Machine Learning Outperforms ACC / AHA CVD Risk Calculator in MESA.

Background Studies have demonstrated that the current US guidelines based on American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equations Risk Calculator may underestimate risk of atherosclerotic cardiovascular disease ( CVD ) in certain high-risk individuals, therefor...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of the American Heart Association Vol. 7; no. 22; pp. 1 - 37
Autores principales: Kakadiaris, Ioannis A., Vrigkas, Michalis, Yen, Albert A., Kuznetsova, Tatiana, Budoff, Matthew, Naghavi, Morteza
Formato: Journal Article
Publicado: Wiley-Blackwell 11/20/2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133263822&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 133263822
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20479980
        FSQ9
      jtl: Journal of the American Heart Association
      issn: 20479980
      maglogo: Y
    pubinfo:
      dt: 11/20/2018
      vid: 7
      iid: 22
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        133263822
        133263822
        NLM30571498
        10.1161/JAHA.118.009476
        NLM30571498
        133263822
      ppf: 1
      ppct: 36
      formats:
      tig:
        atl: Machine Learning Outperforms ACC / AHA CVD Risk Calculator in MESA.
      aug:
        au:
          Kakadiaris, Ioannis A.
          Vrigkas, Michalis
          Yen, Albert A.
          Kuznetsova, Tatiana
          Budoff, Matthew
          Naghavi, Morteza
        affil: Computational Biomedicine Lab, University of Houston, TX
      sug:
        subj:
          Cardiovascular Diseases Diagnosis
          Risk Assessment Methods
          Sensitivity and Specificity
          Cardiovascular Diseases Prevention and Control
          Coronary Arteriosclerosis Diagnosis
          Coronary Arteriosclerosis Etiology
          Coronary Arteriosclerosis Prevention and Control
          Aged
          Risk Factors
          Male
          Cardiovascular Diseases Etiology
          Middle Age
          Antilipemic Agents Therapeutic Use
          Female
          Short Portable Mental Status Questionnaire
          Aged: 65+ years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Background Studies have demonstrated that the current US guidelines based on American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equations Risk Calculator may underestimate risk of atherosclerotic cardiovascular disease ( CVD ) in certain high-risk individuals, therefore missing opportunities for intensive therapy and preventing CVD events. Similarly, the guidelines may overestimate risk in low risk populations resulting in unnecessary statin therapy. We used Machine Learning ( ML ) to tackle this problem. Methods and Results We developed a ML Risk Calculator based on Support Vector Machines ( SVM s) using a 13-year follow up data set from MESA (the Multi-Ethnic Study of Atherosclerosis) of 6459 participants who were atherosclerotic CVD-free at baseline. We provided identical input to both risk calculators and compared their performance. We then used the FLEMENGHO study (the Flemish Study of Environment, Genes and Health Outcomes) to validate the model in an external cohort. ACC / AHA Risk Calculator, based on 7.5% 10-year risk threshold, recommended statin to 46.0%. Despite this high proportion, 23.8% of the 480 "Hard CVD " events occurred in those not recommended statin, resulting in sensitivity 0.76, specificity 0.56, and AUC 0.71. In contrast, ML Risk Calculator recommended only 11.4% to take statin, and only 14.4% of "Hard CVD " events occurred in those not recommended statin, resulting in sensitivity 0.86, specificity 0.95, and AUC 0.92. Similar results were found for prediction of "All CVD " events. Conclusions The ML Risk Calculator outperformed the ACC/AHA Risk Calculator by recommending less drug therapy, yet missing fewer events. Additional studies are underway to validate the ML model in other cohorts and to explore its ability in short-term CVD risk prediction.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N